Preoperative Lymphocyte-to-monocyte Ratio and CA125 Level as Risk Factors for Advanced Ovarian Cancer

Background: Detailed descriptions of the relationship between lymphocyte-to-monocyte ratio alone and combined with CA125 (COLC) and advanced stage of ovarian cancer (OC) have been lacking to date. This study is to analyze the relationship between LMR, CA125 and COLC and advanced stage of OC.Methods: A retrospective clinicopathologic review was performed. The receiver-operating characteristic (ROC) curves of LMR, CA125, and COLC staging OC were constructed. Furthermore, a binary logistic regression model was used to assay the independent risk factors.Results: A total of 225 patients with OC were identified in this cohort. Eighty-five patients with OC were diagnosed at an early stage, and 140 OC patients were diagnosed at an advanced stage. The median of LMR at the early stage was higher than the advanced stage (4.39 vs. 2.78), and the median of CA125 was lower than the advanced stage (80 U/mL vs. 251.25 U/mL). Multivariate logistic regression indicated that LMR (OR=0.314, 95% confidence interval [CI]: 0.143–0.687, P=0.004) and CA125 (OR=4.045, 95%CI: 1.883–8.692, P<0.001) were associated with OC staging. Furthermore, the area under the curve of COLC was higher than that of LMR (0.779 vs. 0.732) or CA125 (0.779 vs. 0.708) in staging OC. The specificity of COLC was higher than that of LMR (87.11% vs. 70.61%) or CA125 (87.11% vs. 61.21%) in staging OC.Conclusions: LMR alone or in combination with CA125 might be associated with OC staging. Besides, as a predictive factor, COLC may have high specificity in staging OC.

[1]  Shee-Uan Chen,et al.  Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study , 2020, Reproductive Biology and Endocrinology.

[2]  D. Lin,et al.  Combined Preoperative LMR and CA125 for Prognostic Assessment of Ovarian Cancer , 2020, Journal of Cancer.

[3]  S. Ju,et al.  Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125 , 2019, Journal of Ovarian Research.

[4]  S. Moestrup,et al.  Specific targeting of CD163+ TAMs mobilizes inflammatory monocytes and promotes T cell–mediated tumor regression , 2019, The Journal of experimental medicine.

[5]  Y. Huang,et al.  Prognostic value of lymphocyte-to-monocyte ratio in ovarian cancer: a meta-analysis , 2019, Journal of Ovarian Research.

[6]  A. Piché,et al.  Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway , 2019, BMC cancer.

[7]  N. Winer,et al.  Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review , 2019, Journal of Ovarian Research.

[8]  Jae-Weon Kim,et al.  A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms , 2019, The New England journal of medicine.

[9]  Zena Werb,et al.  Roles of the immune system in cancer: from tumor initiation to metastatic progression , 2018, Genes & development.

[10]  A. Jemal,et al.  Ovarian cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[11]  T. Morikawa,et al.  LMR predicts outcome in patients after preoperative chemoradiotherapy for stage II-III rectal cancer. , 2018, The Journal of surgical research.

[12]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[13]  Hongyan Wang,et al.  The effect of CA125 on metastasis of ovarian cancer: old marker new function , 2017, Oncotarget.

[14]  Yang Bai,et al.  The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer , 2017, Oncotarget.

[15]  L. Puskás,et al.  Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters , 2017, Mediators of inflammation.

[16]  P. Goodfellow,et al.  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target , 2017, Oncogene.

[17]  Xipeng Wang,et al.  Differential distribution of tumor-associated macrophages and Treg/Th17 cells in the progression of malignant and benign epithelial ovarian tumors , 2016, Oncology letters.

[18]  Wang Min,et al.  Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. , 2016, The Journal of clinical investigation.

[19]  J. Lee,et al.  The Lymphocyte-Monocyte Ratio Predicts Patient Survival and Aggressiveness of Endometrial Cancer , 2016, Journal of Cancer.